Physical activity in established rheumatoid arthritis and variables associated with maintenance of physical activity over a seven-year period – a longitudinal observational study

Table 3 Variables (from 2010) associated with a deterioration in in physical activity level between 2010 and 2017 (n = 234) vs. meeting MVPA recommendations at both occasions (n = 389). A logistic regression model adjusted for age, gender, and smoking habits

2010		n^a	OR	95% CI	p-value
Age		616	1.037	1.022–1.053	< 0.001
Gender	men	162	1
	women	454	1.118	0.759–1.647	0.572
Smoking habits	Non smoker	264	1
	Smoker	93	1.572	0.956–2.587	0.075
	Previous smoker	259	1.263	0.873–1.826	0.216
Disease duration, years		616	0.969	0.928–1.013	0.164
BMI	18.5–24.9, %	290	1
	< 18.5, %	7	2.361	0.502–11.097	0.277
	25.0–29.9, %	238	1.702	1.180–2.468	0.005
	≥30, %	69	2.015	1.161–3.500	0.013
Cardiovasc	no	375	1
	yes	235	1.863	1.290–2.691	0.001
Pulmonary	no	565	1
	yes	47	2.106	1.129–3.927	0.019
TJC		610	1.033	1.006–1.061	0.016
SJC		606	1.025	0.992–1.059	0.138
PatGA (0–10)		611	1.076	0.997–1.160	0.059
Pain (0–10)		607	1.087	1.014–1.164	0.018
Fatigue (0–10)		611	1.072	1.007–1.142	0.030
HAQ (0–3)		611	1.630	1.167–2.278	0.004
EQ 5D (0–1)		605	0.382	0.162–0.899	0.028
Tender regions (0–18)		615	1.076	1.028–1.126	0.002
DMARD	No DMARD	103	1
	cDMARD^b	335	1.572	0.960–2.574	0.072
	Biologic^b	161	1.491	0.858–2.589	0.156
	Only CS	15	1.493	0.472–4.720	0.495

^a included in the multivariate analyses, ^bwith and without corticosteroids
BMI Body mass index, TJC Tender joint count, SJC Swollen joint count, PatGA Patient Global Assessment, NRS Numeric rating scale, HAQ Health Assessment Questionnaire, EQ. 5D Euroqol 5 Dimensions, DMARDs Disease modifying anti-rheumatic drugs, cDMARDs Conventional DMARDs, CS Corticosteroids

ISSN: 2520-1026